Anti-inflammatory Agents Part II - 1st Edition - ISBN: 9780126239027, 9780323152112

Anti-inflammatory Agents Part II

1st Edition

Chemistry and Pharmacology

Editors: Robert Scherrer
eBook ISBN: 9780323152112
Imprint: Academic Press
Published Date: 1st January 1974
Page Count: 400
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST
× DRM-Free

Easy - Download and start reading immediately. There’s no activation process to access eBooks; all eBooks are fully searchable, and enabled for copying, pasting, and printing.

Flexible - Read on multiple operating systems and devices. Easily read eBooks on smart phones, computers, or any eBook readers, including Kindle.

Open - Buy once, receive and download all available eBook formats, including PDF, EPUB, and Mobi (for Kindle).

Institutional Access

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Medicinal Chemistry: A Series of Monographs, Volume 13–II presents the context of inflammation and the therapeutic interventions in debilitating chronic inflammatory diseases. This book discusses the progress of therapeutics in the field of medicine with less cost but with the same degree of benefit. Comprised of 10 chapters, this volume begins with a discussion on the pathophysiological context of chronic inflammatory diseases. This book then explores the local hormones that act as alarm signals following a local injury, which includes serotonin, histamine, kinins, heparin, prostaglandin, adenylates, lysolecithins, and catecholamines. Other chapters feature contributors who have active research on the clinical evaluation and treatment of severely debilitating chronic inflammatory diseases, including gout, arthritis, rheumatoid arthritis, osteoarthritis, psoriasis, and systemic lupus erythematosus. The final chapter explores the metabolism of anti-inflammatory drugs that are organized around chemical classes of compounds. This book is a valuable source of information for physicians, chemists, and experimental biologists.

Table of Contents

List of Contributors


Contents of Volume I

Biological Properties and Clinical Evaluation

Chapter 1 Introduction and Background to the Regulation of Inflammation and the Immune Response

I. The Cost and Benefit of Inflammation and Its Therapy

II. Local Hormones as Inflammagens and Mediators

III. Macromolecular Mediators of Inflammation (and Repair)

IV. Cellular Mediators of Inflammation

V. Tissue Components

VI. In Retrospect

VII. Strategies for Drug Intervention

VIII. The Double Standard

IX. In Prospect

X. A Critical Appraisal of the Factors Inherent in the Testing of New Compounds

XI. Targets in Inflammatory Therapy

XII. The Clinical Evaluation of Antiarthritic Drugs

XIII. Appendix: A Brief Bibliography of Inflammation


Chapter 2 Evaluation for Antiinflammatory Activity


I. Method of Assay: The Modification of One of the Cardinal Signs of Inflammation

II. Method of Assay: The Modification of One of the Events Occurring during the Inflammatory Process

III. Method of Assay: The Possession of a Property That Has Been Associated with a Class of Drugs Known to Be Antiinflammatory

IV. Method of Assay: The Modification of Syndromes Purported to Be Animal Models for Human Rheumatoid Diseases

V. Summary


Chapter 3 Evaluation for Immunosuppressive and Antiallergic Activity

I. Introduction

II. Site of Action

III. Laboratory Evaluation

IV. Immediate-Type (Humoral) Hypersensitivity

V. Delayed-Type (Cellular) Hypersensitivity

VI. Addendum


Chapter 4 Assessment of the Toxicity of Antiinflammatory Drugs

I. Introduction

II. General Considerations of Toxicological Testing

III. Assessment of Pathophysiological Responses to Drugs by Organ Systems

IV. Cytotoxic Drugs

V. Conclusion


Chapter 5 Evaluation for Clinical Efficacy

I. Evaluation of Antietiological Agents (for Eradicating the Prime Cause)

II. Evaluation of Drugs That May Prevent Initial Tissue Injury

III. Evaluation of Classical Antiinflammatory Agents

IV. The Different Phases of a Clinical Trial

V. Appendix


Chapter 6 Drug Kinetic Studies with Nonsteroidal Antiinflammatory Agents in Animals and Man

I. Introduction

II. Comparison of Indomethacin and Phenylbutazone

III. Application to Newer Clinical Agents


Chapter 7 Inhibition of Blood Platelet Function

I. Introduction

II. Role of Platelets in Hemostasis and Thrombosis

III. Effects of Antiinflammatory Drugs on Adhesion of Platelets to Collagen and to Glass

IV. Effects of Antiinflammatory Drugs on the Platelet Release Reaction

V. Effects of Antiinflammatory Drugs on Platelet Aggregation

VI. Effects of Antiinflammatory Drugs In Vivo

VII. Mechanisms of Action

VIII. Conclusion


Chapter 8 Molecular and Cellular Pharmacology of the Antiinflammatory Drugs: Some In Vitro Properties Related to Their Possible Modes of Action

I. Introduction

II. Activities Involving Protein Binding

III. Prostaglandins

IV. Effects on Cells and Membranes

V. Evaluation

VI. Appendix


Chapter 9 Some Effects of Antiinflammatory Drugs on Connective Tissue Metabolism

I. Brief Review of Connective Tissue Structure and Metabolism

II. Effect of Antiinflammatory Drugs on Mucopolysaccharide Metabolism

III. Effect of Antiinflammatory Drugs on Collagen Metabolism

IV. Conclusions


Chapter 10 Metabolism of Selected Antiinflammatory Compounds

I. Introduction

II. Aspirin

III. Phenylbutazone and Some Other Noncarboxylic Acids

IV. Indomethacin

V. Fenamic Acids

VI. Methanesulfonanilides

VII. Concluding Remarks


Author Index

Subject Index


No. of pages:
© Academic Press 1974
Academic Press
eBook ISBN:

About the Editor

Robert Scherrer

Ratings and Reviews